Features | Partner Sites | Information | LinkXpress
Sign In
Schiller
GLOBETECH PUBLISHING
Ampronix

Artificial Implant Prosthesis Could Replace Spinal Fusion

By HospiMedica International staff writers
Posted on 13 Jan 2014
Image: The Total Posterior Solution (TOPS) system (Photo courtesy of Premia Spine).
Image: The Total Posterior Solution (TOPS) system (Photo courtesy of Premia Spine).
A novel artificial spinal joint restores function to the posterior spinal column in people suffering from spinal stenosis.

The Total Posterior Solution (TOPS) system is a titanium-sandwiched implant that effectively replaces anatomical structures removed from the vertebrae during the spinal decompression treatment to alleviate pain, such as the lamina or the facet joint. Thus, the boot and internal components of the implant take the place of the supraspinous ligament, interspinous ligament, and ligamentum flavum in their ability to help control flexion. The internal metal stoppers replace the natural bony elements that served as stoppers during axial rotation.

The implant thus allows axial rotation, lateral bending, extension, and flexion, facilitating bending, twisting, and straightening movements at the affected segment of the spine, while blocking excessive posterior and anterior sagittal translation. Once a controlled range of movement is reestablished, patients regain their ability to bend, flex, walk, and enjoy the normal activities of life, while at the same time experiencing immediate and sustained pain relief. The system also protects adjacent levels of the spine from similar degeneration, a common unwanted side effect of fusion surgery.

As with most spinal fusion devices, the TOPS System is anchored to the spine with four standard polyaxial pedicle screws, and is implanted via a traditional posterior surgical approach. The system is intended for adult patients following decompression surgery to alleviate pain stemming from spinal stenosis and/or degenerative spondylolisthesis affecting the L3-L5 lumbar region of the spine, when nonsurgical treatments have failed to provide relief. The TOPS System is a product of Premia Spine (Netanya, Israel), and can be used in conjunction with Premia Spine's Versalink Fixation System to address multilevel diseases of the spine.

“We’ve developed an implant that recreates all functions of the posterior spinal column, where there are important joints, ligaments, and bony structures that provide control over twisting, bending, and flexing,” said Ron Sacher, CEO of Premia Spine. “With the TOPS System, instead of immobilizing we replace the diseased segment with an artificial joint.”

Related Links:

Premia Spine



MinXray
Centurion Service
Bovie Medical

Channels

Critical Care

view channel
Image: The Trellis peripheral infusion system (Photo courtesy of Covidien).

Thrombolytic Drug Delivery Device Dissolves Blood Clots

A redesigned peripheral infusion system enables focused treatment of blood clots to avoid potential post-thrombotic syndrome (PTS). The updated Trellis peripheral infusion system is a pharmacomechanical... Read more

Women's Health

view channel

More Midwives Could Avert Millions of Deaths

A modest increase in the number of skilled midwives in the world’s poorest nations could save the lives of a substantial number of women and their babies, according to a new study. Researchers at the Johns Hopkins Bloomberg School of Public Health (Baltimore, MD, USA) used the Lives Saved Tool (LiST) to estimate deaths... Read more

Health IT

view channel

Wikipedia Dominates Internet Drug Information

Wikipedia, along with Google and WebMD, is where more than half of all Americans turn to for health information on prescription drugs. Researchers at the Blackstone Group (London, United Kingdom), Harvard Medical School (Boston, MA, USA), and other institutions selected new drug-safety communications related to prescription... Read more

Business

view channel

Spectranetics Completes Acquisition of AngioScore

Spectranetics (Colorado Springs, CO, USA) has completed the acquisition of AngioScore (Fremont, CA, USA), a leading developer, manufacturer, and marketer of cardiovascular specialty balloons. The transaction, for USD 230 million in cash and contingent commercial and regulatory milestone payments, will combine differentiated,... Read more
 
Copyright © 2000-2014 Globetech Media. All rights reserved.